Ipatasertib (GDC-0068)

Catalog No.S2808 Synonyms: RG7440

Ipatasertib (GDC-0068) Chemical Structure

Molecular Weight(MW): 458

Ipatasertib (GDC-0068) is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM in cell-free assays, 620-fold selectivity over PKA. Phase 2.

Size Price Stock Quantity  
In DMSO USD 378 In stock
USD 270 In stock
USD 370 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

2 Customer Reviews

  • Inhibition of AKT signaling abolishes MKK4 phosphorylation on Ser78 in injured axons. Cultures of sensory neurons were treated with 5 µM MK-2206 or 5 µM GDC-0068 for 1 hr prior to axotomy. Axonal proteins harvested at indicated time points after axotomy were subjected to immunoblot analysis.

    Cell, 2015, 160(1-2): 161-76 . Ipatasertib (GDC-0068) purchased from Selleck.

    In vitro evaluation of BAR activity in A549-BAR cell line. (A) Bioluminescence activity was quantified 1 hour after treatment in response to various compounds at two concentrations (n = 6). (B) Western blotting analysis after 1 hour of treatment showing the expression of pAKT (Ser473), AKT, pPRAS40 (Thr246), RAS40, pGSK3β (Ser9), GSK3β, pEGFR (Tyr1068), EGFR, and β-Actin of whole cell lysates.

    Neoplasia, 2017, 19(4):310-320. Ipatasertib (GDC-0068) purchased from Selleck.

Purity & Quality Control

Choose Selective Akt Inhibitors

Biological Activity

Description Ipatasertib (GDC-0068) is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM in cell-free assays, 620-fold selectivity over PKA. Phase 2.
Akt1 [1]
(Cell-free assay)
Akt3 [1]
(Cell-free assay)
Akt2 [1]
(Cell-free assay)
5 nM 8 nM 18 nM
In vitro

Testing against a broad panel of 230 kinases, GDC-0068 only inhibits 3 kinases by >70% at 1 μM concentration (PRKG1α, PRKG1β, and p70S6K, with IC50 of 98 nM, 69 nM, and 860 nM, respectively). GDC-0068 displays >100-fold selectivity for Akt over PKA with IC50 of 3.1 μM. In LNCaP, PC3 and BT474M1 cells, GDC-0068 treatment inhibits the phosphorylation of the Akt substrate, PRAS40 with IC50 of 157 nM, 197 nM, and 208 nM, respectively. Furthermore, GDC-0068 selectively inhibits cell cycle progression and viability of cancer cell lines driven by Akt signaling, including those with defects in the tumor suppressor PTEN, oncogenic mutations in PIK3CA, and amplification of HER2, with strongest effects in HER2+ and Luminal subtypes. [1-4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HCC70  M1q0cWZ2dmO2aX;uJGF{e2G7 MXuxJO69VQ>? NVzWOINsOjRiaB?= NWTaeYpvcW6lcnXhd4V{KHSqZTDhZpVv\GGwY3Wgc4YhUEWUMzDhcoQhcW6mdXPld{B1cGVicHjvd5Bpd3K7bHH0bY9vKCijY4TpeoF1cW:wKTDv[kBjd3SqIFXHSnIh[W6mIFjFVlM> M4TNdVI1PjZ5M{e2
MDA-MB-468  M1nkXWZ2dmO2aX;uJGF{e2G7 M3zoPFEh|ryP MWOyOEBp MmfnbY5kemWjc3XzJJRp\SCjYoXu[IFv[2Vib3[gTGVTOw>? NEPyb3gzPDZ4N{O3Oi=>
HCC70  NGDwWoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2DBblEh|ryP NWfhNXN1PSCm M{\UR4VvcGGwY3XzJJRp\SCjboTpdJJwdGmoZYLheIl3\SC{ZYPwc45{\Q>? M{ewdFI1PjZ5M{e2
MDA-MB-468  MmewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWWxJO69VQ>? M33yclUh\A>? NHSxWWhmdmijbnPld{B1cGViYX70bZBzd2yrZnXyZZRqfmVicnXzdI9ve2V? NXTBOmZSOjR4NkezO|Y>
PC-3 NUT5eJB1TnWwY4Tpc44hSXO|YYm= Mn:xNE4xODN6LUKuOUDPxE1? NX7aOmlsOSCq NIP1XlBFVVOR M4DGWYlv\HWlZYOgZUBld3OnLXTldIVv\GWwdDDpcoNz\WG|ZTDpckBCc3RicHjvd5Bpd3K7bHH0bY9vKGG2IHLveIghXGi{M{C4xsApXDNyODmgZY5lKFOnckS3Ny=> MYmyN|I5PzV4Mx?=
BT474M1 NX7q[|RDTnWwY4Tpc44hSXO|YYm= M2TZRVAvODB|OD2yMlUh|ryP MXOxJIg> M1zOSWROW09? MXTpcoR2[2W|IHGg[I9{\S2mZYDlcoRmdnRiaX7jdoVie2ViaX6gRYt1KHCqb4PwbI9zgWyjdHnvckBifCCkb4ToJHRpejNyONMgLHQ{ODhrIHHu[EBU\XJ2N{O= M2LleVI{Ojh5NU[z
IGROV-1 NVy0cHFbTnWwY4Tpc44hSXO|YYm= MlLlNE4xODN6LUKuOUDPxE1? MVixJIg> M2H3bGROW09? Mkj4bY5lfWOnczDhJIRwe2VvZHXw[Y5l\W62IHnuZ5Jm[XOnIHnuJGFsfCCyaH;zdIhwenmuYYTpc44h[XRiYn;0bEBVcHJ|MElCpEhVOzB6KTDhcoQhW2W{NEez NXnnXlhvOjN{OEe1OlM>
PC-3 M3zxTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVT4eGNyOS93L{GwJO69VQ>? NEfJfoQzPC92OD:3NkBp M2rnW2ROW09? M32xZYRwe2VvZHXw[Y5l\W62bImgbY5kemWjc3XzJJRp\SCJMPMAl2cyyqCyaHHz[UBxd3C3bHH0bY9vyqB? M3zZTVI{Ojh5NU[z
MCF7-neo/HER2 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml64NU82NzFyIN88US=> M{PySlI1NzR6L{eyJIg> NXfoe5h1TE2VTx?= NWHqb|hp\G:|ZT3k[ZBmdmSnboTsfUBqdmO{ZXHz[ZMhfGinIFew5qCUTzIEoIDoZZNmKHCxcIXsZZRqd28EoB?= MkHjNlMzQDd3NkO=
BT474M1 NGruU|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1zvcVEwPS9zMDFOwG0> NYDVOmtDOjRxNEivO|IhcA>? NVLLSJVsTE2VTx?= M3G2d4Rwe2VvZHXw[Y5l\W62bImgbY5kemWjc3XzJJRp\SCJMPMAl2cyyqCyaHHz[UBxd3C3bHH0bY9vyqB? MWCyN|I5PzV4Mx?=
PC-3 MnKyRZBweHSxc3nzJGF{e2G7 NF3TfVcyNzVxMUCg{txO MoGwNVUwPDhxN{KgbC=> M{DGbGROW09? NH3Hfmdk[XW|ZYOgZUBld3OnLTDhcoQhfGmvZT3k[ZBmdmSnboSgbY5kemWjc3WgbY4h[XCxcITveIlkKGGwZDDu[YNzd3SrYzDwc5B2dGG2aX;udy=> MkO0NlMzQDd3NkO=
MCF7-neo/HER2 NUPic2VxSXCxcITvd4l{KEG|c3H5 NFX0[oUyNzVxMUCg{txO NWnPcXV7OTVxNEivO|IhcA>? M1jZfGROW09? NGizO2pk[XW|ZYOgZUBld3OnLTDhcoQhfGmvZT3k[ZBmdmSnboSgbY5kemWjc3WgbY4h[XCxcITveIlkKGGwZDDu[YNzd3SrYzDwc5B2dGG2aX;udy=> NULMW21QOjN{OEe1OlM>
BT474M1 M1PVSmFxd3C2b4Ppd{BCe3OjeR?= MkTyNU82NzFyIN88US=> M{TrVlE2NzR6L{eyJIg> NVzPU29yTE2VTx?= M3noWINifXOnczDhJIRwe2VvIHHu[EB1cW2nLXTldIVv\GWwdDDpcoNz\WG|ZTDpckBieG:ydH;0bYMh[W6mIH7lZ5JwfGmlIIDvdJVt[XSrb37z MXGyN|I5PzV4Mx?=

... Click to View More Cell Line Experimental Data

In vivo Oral administration of GDC-0068 in PC3 prostate tumor xenografts model induces down-regulation of p-PRAS40. In BT474-Tr xenografts, GDC-0068 treatment reduces pS6 and peIF4G levels, re-localizes FOXO3a to nucleus, and induces feedback upregulation of HER3 and pERK. Administration of GDC-0068 exhibits potent antitumor efficacy in multiple xenograft tumor models, including the PTEN-deficient prostate cancer models LNCaP and PC3, the PIK3CA H1047R mutant breast cancer model KPL-4, and MCF7-neo/HER2 tumor model. [1-4]


Animal Research:[1]
+ Expand
  • Animal Models: Female nude mice bearing LNCaP, PC3, KPL-4, or MCF7 tumor xenografts
  • Formulation: Formulated in 0.5% methylcellulose/0.2% Tween-80
  • Dosages: ~100 mg/kg/day
  • Administration: Orally
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 92 mg/mL (200.87 mM)
Ethanol 92 mg/mL (200.87 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 458


CAS No. 1001264-89-6
Storage powder
Synonyms RG7440

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01896531 Active, not recruiting Gastric Cancer Genentech, Inc. August 2013 Phase 2
NCT01485861 Active, not recruiting Prostate Cancer Genentech, Inc. December 2011 Phase 1|Phase 2
NCT01362374 Active, not recruiting Solid Cancers Genentech, Inc. July 2011 Phase 1
NCT01090960 Completed Solid Cancers Genentech, Inc. March 2010 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Akt Signaling Pathway Map

Akt Inhibitors with Unique Features

Related Akt Products

Tags: buy Ipatasertib (GDC-0068) | Ipatasertib (GDC-0068) supplier | purchase Ipatasertib (GDC-0068) | Ipatasertib (GDC-0068) cost | Ipatasertib (GDC-0068) manufacturer | order Ipatasertib (GDC-0068) | Ipatasertib (GDC-0068) distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID